» Articles » PMID: 23258923

Distinct Gene-expression Profiles Associated with the Susceptibility of Pathogen-specific CD4 T Cells to HIV-1 Infection

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2012 Dec 22
PMID 23258923
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

In HIV infection, CD4 responses to opportunistic pathogens such as Candida albicans are lost early, but CMV-specific CD4 response persists. Little is currently known about HIV infection of CD4 T cells of different pathogen/antigen specificities. CFSE-labeled PBMCs were stimulated with CMV, tetanus toxoid (TT), and C albicans antigens and subsequently exposed to HIV. HIV infection was monitored by intracellular p24 in CFSE(low) population. We found that although TT- and C albicans-specific CD4 T cells were permissive, CMV-specific CD4 T cells were highly resistant to both R5 and X4 HIV. Quantification of HIV DNA in CFSE(low) cells showed a reduction of strong-stop and full-length DNA in CMV-specific cells compared with TT- and C albicans-specific cells. β-Chemokine neutralization enhanced HIV infection in TT- and C albicans-specific cells, whereas HIV infection in CMV-specific cells remained low despite increased entry by β-chemokine neutralization, suggesting postentry HIV restriction by CMV-specific cells. Microarray analysis (Gene Expression Omnibus accession number: GSE42853) revealed distinct transcriptional profiles that involved selective up-regulation of comprehensive innate antiviral genes in CMV-specific cells, whereas TT- and C albicans-specific cells mainly up-regulated Th17 inflammatory response. Our data suggest a mechanism for the persistence of CMV-specific CD4 response and earlier loss of mucosal Th17-associated TT- and C albicans-specific CD4 response in AIDS.

Citing Articles

Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infection.

Kiessling M, Cole J, Kubel S, Klein P, Korn K, Henry A Nat Commun. 2024; 15(1):10200.

PMID: 39587133 PMC: 11589758. DOI: 10.1038/s41467-024-54605-3.


HIV Expression in Infected T Cell Clones.

Rausch J, Parvez S, Pathak S, Capoferri A, Kearney M Viruses. 2024; 16(1).

PMID: 38257808 PMC: 10820123. DOI: 10.3390/v16010108.


Antigen specificities of HIV-infected cells: A role in infection and persistence?.

Faua C, Fafi-Kremer S, Gantner P J Virus Erad. 2023; 9(2):100329.

PMID: 37440870 PMC: 10334354. DOI: 10.1016/j.jve.2023.100329.


Glycan dependent phenotype differences of HIV-1 generated from macrophage versus CD4 T helper cell populations.

Heeregrave E, Thomas J, van Capel T, de Jong E, Pollakis G, Paxton W Front Immunol. 2023; 14:1107349.

PMID: 37415979 PMC: 10320205. DOI: 10.3389/fimmu.2023.1107349.


HSV-2 triggers upregulation of MALAT1 in CD4+ T cells and promotes HIV latency reversal.

Pierce C, Loh L, Steach H, Cheshenko N, Preston-Hurlburt P, Zhang F J Clin Invest. 2023; 133(11).

PMID: 37079384 PMC: 10232005. DOI: 10.1172/JCI164317.


References
1.
Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave E . Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med. 2010; 207(13):2869-81. PMC: 3005236. DOI: 10.1084/jem.20100090. View

2.
Lu J, Pan Q, Rong L, He W, Liu S, Liang C . The IFITM proteins inhibit HIV-1 infection. J Virol. 2010; 85(5):2126-37. PMC: 3067758. DOI: 10.1128/JVI.01531-10. View

3.
Hu H, Fernando K, Ni H, Weissman D . HIV envelope suppresses CD4+ T cell activation independent of T regulatory cells. J Immunol. 2008; 180(8):5593-600. DOI: 10.4049/jimmunol.180.8.5593. View

4.
Picker L . Immunopathogenesis of acute AIDS virus infection. Curr Opin Immunol. 2006; 18(4):399-405. DOI: 10.1016/j.coi.2006.05.001. View

5.
Ramilo O, Bell K, UHR J, Vitetta E . Role of CD25+ and CD25-T cells in acute HIV infection in vitro. J Immunol. 1993; 150(11):5202-8. View